Atrial and brain natriuretic peptide concentrations and the response to inhaled nitric oxide in patients with acute respiratory distress syndrome

Journal of Critical Care

Volumn 25, Issue 1, 2010, Pages 23-29

  Treggiari, Miriam M ^a   Bendjelid, Karim ^b   Yanez, N David ^c   Heidegger, Claudia Paula ^b   Suter, Peter M ^d   Romand, Jacques André ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Acute lung injury; Adult respiratory distress syndrome; Atrial natriuretic factor; Cardiac natriuretic peptide hormones; Human

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; NITRIC OXIDE;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HEART OUTPUT; HEART RATE; HUMAN; LUNG HEMODYNAMICS; LUNG MINUTE VOLUME; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; OXYGENATION; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTEMIC PULMONARY SHUNT;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; ATRIAL NATRIURETIC FACTOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NITRIC OXIDE; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77049101496     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2008.10.014     Document Type: Article

References (33)

1. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 (1994) 818-824
2. Rossaint R., Falke K.J., Lopez F., et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328 (1993) 399-405
3. Dellinger R.P., Zimmerman J.L., Taylor R.W., et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 26 (1998) 15-23
4. Michael J.R., Barton R.G., Saffle J.R., et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 157 (1998) 1372-1380
5. Troncy E., Collet J.P., Shapiro S., et al. Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med 157 (1998) 1483-1488
6. Lundin S., Mang H., Smithies M., et al. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med 25 (1999) 911-919
7. Taylor R.W., Zimmerman J.L., Dellinger R.P., et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. Jama 291 (2004) 1603-1609
8. Rossaint R., Pison U., Gerlach H., et al. Inhaled nitric oxide: its effects on pulmonary circulation and airway smooth muscle cells. Eur Heart J 14 Suppl I (1993) 133-140
9. Treggiari-Venzi M., Ricou B., Romand J.A., et al. The response to repeated nitric oxide inhalation is inconsistent in patients with acute respiratory distress syndrome. Anesthesiology 88 (1998) 634-641
10. Manktelow C., Bigatello L.M., Hess D., et al. Physiologic determinants of the response to inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 87 (1997) 297-307
11. McIntyre Jr. R.C., Moore F.A., Moore E.E., et al. Inhaled nitric oxide variably improves oxygenation and pulmonary hypertension in patients with acute respiratory distress syndrome. J Trauma 39 (1995) 418-425
12. Gust R., McCarthy T.J., Kozlowski J., et al. Response to inhaled nitric oxide in acute lung injury depends on distribution of pulmonary blood flow prior to its administration. Am J Respir Crit Care Med 159 (1999) 563-570
13. Lukaszewicz A.C., Mebazaa A., Callebert J., et al. Lack of alteration of endogenous nitric oxide pathway during prolonged nitric oxide inhalation in intensive care unit patients. Crit Care Med 33 (2005) 1008-1014
14. Langleben D., DeMarchie M., Laporta D., et al. Endothelin-1 in acute lung injury and the adult respiratory distress syndrome. Am Rev Respir Dis 148 (1993) 1646-1650
15. Leskinen H., Vuolteenaho O., Leppaluoto J., et al. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-l-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release. Endocrinology 136 (1995) 1241-1249
16. Amin J., Carretero O.A., and Ito S. Mechanisms of action of atrial natriuretic factor and C-type natriuretic peptide. Hypertension 27 (1996) 684-687
17. Rosenzweig A., and Seidman C.E. Atrial natriuretic factor and related peptide hormones. Ann Rev Biochem 60 (1991) 229-255
18. Takahashi M., Takeda S., Kurokawa S., et al. Cyclic GMP production by ANP, BNP, and NO during worsening and improvement of chronic heart failure. Jpn Heart J 44 (2003) 713-724
19. Maeder M., Ammann P., Rickli H., et al. Elevation of B-type natriuretic peptide levels in acute respiratory distress syndrome. Swiss Med Wkly 133 (2003) 515-518
20. Germann P., Braschi A., Della Rocca G., et al. Inhaled nitric oxide therapy in adults: European expert recommendations. Intensive Care Med 31 (2005) 1029-1041
21. Adnot S., Andrivet P., Chabrier P.E., et al. Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion. J Clin Invest 83 (1989) 986-993
22. Andrivet P., Chabrier P.E., Defouilloy C., et al. Intravenously administered atrial natriuretic factor in patients with COPD. Effects on ventilation-perfusion relationships and pulmonary hemodynamics. Chest 106 (1994) 118-124
23. Mitaka C., Hirata Y., Nagura T., et al. Increased plasma concentrations of brain natriuretic peptide in patients with acute lung injury. J Crit Care 12 (1997) 66-71
24. Nagaya N., Nishikimi T., Okano Y., et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 31 (1998) 202-208
25. Vieillard-Baron A., Charron C., Caille V., et al. Prone positioning unloads the right ventricle in severe ARDS. Chest 132 (2007) 1440-1446
26. Bendjelid K. Impact of pulmonary artery occlusion pressure value on the definition of acute respiratory distress syndrome. Intensive Care Med 29 (2003) 499 [author reply 500]
27. Vieillard-Baron A., and Jardin F. Why protect the right ventricle in patients with acute respiratory distress syndrome?. Curr Opin Crit Care 9 (2003) 15-21
28. Ghofrani H.A., Wiedemann R., Rose F., et al. Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: responders versus nonresponders. Eur Respir J 19 (2002) 664-671
29. Zwissler B., Kemming G., Merkel M., et al. Response to inhaled nitric oxide (NO) is not associated with changes of plasma cGMP levels in patients with acute lung injury. Eur J Med Res 4 (1999) 463-467
30. Kucher N., Printzen G., Doernhoefer T., et al. Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation 107 (2003) 1576-1578
31. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
32. Castillo J.R., Zagler A., Carrillo-Jimenez R., et al. Brain natriuretic peptide: a potential marker for mortality in septic shock. Int J Infect Dis 8 (2004) 271-274
33. Maisel A.S., Koon J., Krishnaswamy P., et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 141 (2001) 367-374